ATE96426T1 - Diphenylharnstoffderivate. - Google Patents

Diphenylharnstoffderivate.

Info

Publication number
ATE96426T1
ATE96426T1 AT90111195T AT90111195T ATE96426T1 AT E96426 T1 ATE96426 T1 AT E96426T1 AT 90111195 T AT90111195 T AT 90111195T AT 90111195 T AT90111195 T AT 90111195T AT E96426 T1 ATE96426 T1 AT E96426T1
Authority
AT
Austria
Prior art keywords
carbon atoms
alkyl group
atom
urea derivatives
diphenyl urea
Prior art date
Application number
AT90111195T
Other languages
English (en)
Inventor
Tetsuo Sekiya
Shinya Inoue
Masao Taniguchi
Kohei Umezu
Kazuo Suzuki
Original Assignee
Mitsubishi Chem Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Ind filed Critical Mitsubishi Chem Ind
Application granted granted Critical
Publication of ATE96426T1 publication Critical patent/ATE96426T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT90111195T 1989-06-15 1990-06-13 Diphenylharnstoffderivate. ATE96426T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15259489 1989-06-15
JP2106986A JPH0395153A (ja) 1989-06-15 1990-04-23 ジフェニル尿素誘導体
EP90111195A EP0405233B1 (de) 1989-06-15 1990-06-13 Diphenylharnstoffderivate

Publications (1)

Publication Number Publication Date
ATE96426T1 true ATE96426T1 (de) 1993-11-15

Family

ID=26447071

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90111195T ATE96426T1 (de) 1989-06-15 1990-06-13 Diphenylharnstoffderivate.

Country Status (10)

Country Link
US (1) US5063247A (de)
EP (1) EP0405233B1 (de)
JP (1) JPH0395153A (de)
KR (1) KR910000628A (de)
AT (1) ATE96426T1 (de)
AU (1) AU628583B2 (de)
CA (1) CA2018848A1 (de)
DE (1) DE69004164T2 (de)
DK (1) DK0405233T3 (de)
ES (1) ES2059893T3 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100915A (en) * 1991-02-19 1996-03-31 Erba Carlo Spa Disubstituted ureas and thioureas their preparation and pharmaceutical compositions containing them
US5420164A (en) * 1991-04-04 1995-05-30 Yoshitomi Pharmaceutical Industries, Ltd. Cycloalkylurea compounds
HUT62558A (en) * 1991-07-01 1993-05-28 Sandoz Ag Process for producing n-phenylthiourea derivaties and pharmaceutical compositions comprising same
DE4126662A1 (de) * 1991-08-13 1993-02-18 Boehringer Mannheim Gmbh Neue 3,5-di-tert.butyl-4-hydroxyphenyl-derivate, verfahren zu ihrer herstellung und arzneimittel
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
EP0742208A1 (de) * 1995-05-05 1996-11-13 Grelan Pharmaceutical Co., Ltd. 2-Ureido-benzamid-Derivate
NZ299242A (en) * 1995-09-11 1997-12-19 Nihon Nohyaku Co Ltd N-phenyl-n'-(phenyl substituted imidazol-5-yl, -oxazol-4-yl, and -thiazol-4-yl)urea derivatives
EP0773218A1 (de) * 1995-11-13 1997-05-14 Mitsubishi Chemical Corporation N-(Piperazinylalkoxyphenyl)-N'-phenylalkylharnstoffderivate als ACAT-Hemmer zur Atherosklerosebehandlung
CA2197364A1 (en) * 1996-02-15 1997-08-16 Toshikazu Suzuki Phenol compound and process for preparing the same
US6344476B1 (en) 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP1140840B1 (de) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituierte diphenyl harnstoffe als raf kinase inhibitoren
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
ATE538794T1 (de) 1999-01-13 2012-01-15 Bayer Healthcare Llc Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
RU2319693C9 (ru) 1999-01-13 2008-08-20 Байер Копэрейшн Производные мочевины (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, связанного с ростом раковых клеток (варианты)
EP1308438B9 (de) * 2000-08-10 2012-03-28 Mitsubishi Tanabe Pharma Corporation 3-substituierte harnstoffderivate und deren medizinische verwendung
KR100564902B1 (ko) 2000-08-21 2006-03-30 주식회사 태평양 신규 티오우레아 유도체 및 이를 함유하는 약제학적 조성물
JP2004506714A (ja) 2000-08-21 2004-03-04 パシフィック コーポレーション 新規チオ尿素化合物及びこれを含有する薬学的組成物
KR100407640B1 (ko) * 2000-12-19 2003-12-01 주식회사 태평양 신규한 디페닐 아미드 유도체, 그의 제조방법 및 이를포함하는 약학 및 화장료 조성물
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
US20030216396A1 (en) 2002-02-11 2003-11-20 Bayer Corporation Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
US7838541B2 (en) 2002-02-11 2010-11-23 Bayer Healthcare, Llc Aryl ureas with angiogenesis inhibiting activity
PT1580188E (pt) 2002-02-11 2012-01-25 Bayer Healthcare Llc Aril-ureias como inibidores de cinases
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
WO2004113274A2 (en) 2003-05-20 2004-12-29 Bayer Pharmaceuticals Corporation Diaryl ureas with kinase inhibiting activity
RS52625B (sr) 2003-07-23 2013-06-28 Bayer Healthcare Llc Fluoro supstituisana omega-karboksiaril difenil urea za lečenje i prevenciju bolesti i stanja bolesti
ATE517885T1 (de) 2004-04-30 2011-08-15 Bayer Healthcare Llc Substituierte pyrazolyl-harnstoff-derivate zur behandlung von krebs
JP4602003B2 (ja) * 2004-06-18 2010-12-22 富士フイルム株式会社 チオウレア化合物、ベンゾチアゾール化合物、及びベンゾチアゾリン化合物の製造方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3579578A (en) * 1966-07-08 1971-05-18 Givaudan Corp 3,4-dihalo-3' and 4'-lower alkylcarbanilides
FR2070252A5 (en) * 1969-11-03 1971-09-10 Givaudan & Cie Sa Bacteriostatic carbanilides
US3860645A (en) * 1973-05-23 1975-01-14 Givaudan Corp Bacteriostatic substituted carbanilides
US4218438A (en) * 1979-02-14 1980-08-19 Eli Lilly And Company Anticoccidial combinations comprising nicarbazin and the polyether antibiotics
EP0049538A3 (de) * 1979-07-14 1982-10-13 Bayer Ag Verwendung von Thioharnstoffderivaten als Arzneimittel bei der Behandlung von Fettstoffwechselstörungen
DE2928485A1 (de) * 1979-07-14 1981-01-29 Bayer Ag Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
US4387105A (en) * 1982-01-26 1983-06-07 American Cyanamid Company Methods of treating atherosclerosis with dialkylureas and dialkylthioureas
US5003106A (en) * 1983-07-19 1991-03-26 American Cyanamid Company Antiatherosclerotic ureas and thioureas
IE61716B1 (en) * 1987-06-02 1994-11-30 Warner Lambert Co Antihyperlipidemic and antiatherosclerotic urea compounds
EP0297610B1 (de) * 1987-07-02 1991-03-13 Warner-Lambert Company N-[(2,6-disubstituierte)-Phenyl]-Harnstoff und -Carbamat-Inhibitoren der Acyl-Coenzym A:Cholesterol-Acyltransferase
ATE98223T1 (de) * 1988-03-30 1993-12-15 Warner Lambert Co N-(((2,6-disubstituierte)phenyl>n'- arylalkyl> harnstoffe als antihypercholesterolemische und antiatherosclerotische mittel.
US4868210A (en) * 1988-03-30 1989-09-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US5116848A (en) * 1988-03-30 1992-05-26 Warner-Lambert Company N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents
GB8908063D0 (en) * 1989-04-11 1989-05-24 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
DK0405233T3 (da) 1993-12-20
US5063247A (en) 1991-11-05
DE69004164T2 (de) 1994-04-21
EP0405233B1 (de) 1993-10-27
KR910000628A (ko) 1991-01-29
DE69004164D1 (de) 1993-12-02
CA2018848A1 (en) 1990-12-15
AU5700990A (en) 1990-12-20
JPH0395153A (ja) 1991-04-19
AU628583B2 (en) 1992-09-17
ES2059893T3 (es) 1994-11-16
EP0405233A1 (de) 1991-01-02

Similar Documents

Publication Publication Date Title
DE69004164D1 (de) Diphenylharnstoffderivate.
HUT49860A (en) Process for producing benzamide-type protease inhibitors
ATE61374T1 (de) Diaminoandrostanderivate.
ES2093041T3 (es) Derivados de 2-oxo-(1,8-naftiridina).
ATE115121T1 (de) 1-phenylalkyl-phenylharnstoff-derivate.
ATE127123T1 (de) Biphosphonsäurederivate, produktion und verwendung davon.
HU9400246D0 (en) Modified oligodeoxyribonucleotides, process for producing them, and pharmaceutical compositions containing them
BR8606955A (pt) Processo para preparar uma composicao,concentrado aditivo,composicao lubrificante,composicao combustivel e metodo para reduzir o consumo de combustivel
DE3864707D1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
ATE110375T1 (de) 1-phenylalkyl-3-phenylharnstoff-derivate.
DE69116838D1 (de) Bisphosphonsäurederivate, ihre Produktion und ihre Verwendung
DE69007203D1 (de) Imidazolderivate, Verfahren zu deren Herstellung und diese enthaltende Antiulkusmittel.
ES2144327T3 (es) Procedimiento para preparar un compuesto de 2-cianobifenilo.
FI883507A0 (fi) Naftotiazepinderivat och deras framstaellning.
ATE135693T1 (de) Halogeno-4-methylpyrazole und verfahren zu ihrer herstellung
DE69015220D1 (de) Glycocyamidin-Derivate.
DE3879058D1 (de) 4-piperidincarboxamid-derivate.
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
DE69333903D1 (de) Optisch aktive 1-Phenylpyrrolidonderivate
ES2019633B3 (es) Compuestos de azaantraceno.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee